Cell Painting-Based Tool for the Risk Assessment of Mammary Carcinogens and Endocrine Disruptors
- 1Université Paris Cité, CNRS, Unité de Biologie Fonctionnelle et Adaptative, INSERM U1133
Abstract
Breast cancer is the most common cancer in women worldwide and chemicals disrupting estrogen or progesterone signaling are recognized as potential risk factors. However, chemicals that alter the mammary gland (MG) development and function remain understudied, highlighting the need for additional research in this area. To address this gap, we investigate the relevance of using high-content imaging assays and more specifically, Cell Painting technology to measure cell morphology perturbation caused by chemical exposure and identify morphological features that could characterize mammary carcinogens (MC) risk factors. Using a dataset of MC and non-mammary carcinogens (Non-MC) with Cell Painting profiles from the JUMP-CP dataset, we retrieved 51 compounds: 28 MC, 23 non-genotoxic Non-MC. We characterized the morphological data by non-linear dimensionality reduction (UMAP) and hierarchical clustering. We, then, developed a Guilt-By-Association (GBA) framework comparing multiple configurations of similarity metrics, risk-score aggregation approaches and features representations. Morphological profiles clustered by mechanism of action rather than carcinogenicity label: genotoxic MC produced strong perturbations in endoplasmic reticulum, mitochondria, nucleus, and RNA compartments, whereas hormonally active compounds were indistinguishable from controls, reflecting the lack of functional steroid hormone receptors in the cell line used. Our best GBA configuration achieved an AUC-ROC of 0.630 and an AUC-PR of 0.696. Applied prospectively to endocrine disruptors chemicals, it prioritized clofentezine, 3-methylpyrazole, resorcinol, 2-tert-butyl-4-methoxyphenol, and thiabendazole as candidates for confirmatory testing. This study provides a transparent, interpretable tool for prioritizing chemicals in mammary carcinogenicity assessment, highlights limitations and clarifies where Cell Painting datasets must be complemented by hormone-sensitive models.
Related
- Dysregulation of the vaginal microbiota in endometriosis and impact of endocrine disruptors: an exploratory case-control study
- A single-spheroid bovine mammary co-culture model for longitudinal monitoring and preclinical safety assessment of antimicrobial alternatives against mastitis-causing pathogens
- Painting the evolutionary history of a multicompartmentalized syngameon in North American Castilleja (Orobanchaceae)
- The Oral Virome in Dental Caries: From Ecological Disruptors to Therapeutic Opportunities.
- Cell painting with amphiphile-protein conjugate vaccines drives B cell activation and germinal center priming to enhance humoral immunity
BibTeX
@misc{achebouche2026cell,
title = {{Cell Painting-Based Tool for the Risk Assessment of Mammary Carcinogens and Endocrine Disruptors}},
author = {R. ACHEBOUCHE and O. Taboureau},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.04.749408},
url = {https://www.biorxiv.org/content/10.64898/2026.09.04.749408v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Cell Painting-Based Tool for the Risk Assessment of Mammary Carcinogens and Endocrine Disruptors
AU - R. ACHEBOUCHE
AU - O. Taboureau
PY - 2026
DA - 2026/09/04
PB - bioRxiv
DO - 10.64898/2026.09.04.749408
UR - https://www.biorxiv.org/content/10.64898/2026.09.04.749408v1
AB - Breast cancer is the most common cancer in women worldwide and chemicals disrupting estrogen or progesterone signaling are recognized as potential risk factors. However, chemicals that alter the mammary gland (MG) development and function remain understudied, highlighting the need for additional research in this area. To address this gap, we investigate the relevance of using high-content imaging assays and more specifically, Cell Painting technology to measure cell morphology perturbation caused by chemical exposure and identify morphological features that could characterize mammary carcinogens (MC) risk factors. Using a dataset of MC and non-mammary carcinogens (Non-MC) with Cell Painting profiles from the JUMP-CP dataset, we retrieved 51 compounds: 28 MC, 23 non-genotoxic Non-MC. We characterized the morphological data by non-linear dimensionality reduction (UMAP) and hierarchical clustering. We, then, developed a Guilt-By-Association (GBA) framework comparing multiple configurations of similarity metrics, risk-score aggregation approaches and features representations. Morphological profiles clustered by mechanism of action rather than carcinogenicity label: genotoxic MC produced strong perturbations in endoplasmic reticulum, mitochondria, nucleus, and RNA compartments, whereas hormonally active compounds were indistinguishable from controls, reflecting the lack of functional steroid hormone receptors in the cell line used. Our best GBA configuration achieved an AUC-ROC of 0.630 and an AUC-PR of 0.696. Applied prospectively to endocrine disruptors chemicals, it prioritized clofentezine, 3-methylpyrazole, resorcinol, 2-tert-butyl-4-methoxyphenol, and thiabendazole as candidates for confirmatory testing. This study provides a transparent, interpretable tool for prioritizing chemicals in mammary carcinogenicity assessment, highlights limitations and clarifies where Cell Painting datasets must be complemented by hormone-sensitive models.
ER -